| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1081/DMR-120037570 |
| P698 | PubMed publication ID | 15237860 |
| P2093 | author name string | Patrick J Sinko | |
| Sung-Hack Lee | |||
| Yaming Su | |||
| P2860 | cites work | Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA | Q24564700 |
| MRP3, an organic anion transporter able to transport anti-cancer drugs | Q24650550 | ||
| Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs | Q24681283 | ||
| Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation | Q28218324 | ||
| Type I collagen gel modulates extracellular matrix synthesis and deposition by tracheal epithelial cells | Q28583192 | ||
| P-Glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. | Q32062298 | ||
| Localisation of breast cancer resistance protein in microvessel endothelium of human brain | Q33962609 | ||
| Permeability of bovine brain microvessel endothelial cells in vitro: barrier tightening by a factor released from astroglioma cells | Q33969609 | ||
| The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors | Q34065800 | ||
| Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma. | Q34190633 | ||
| Antiretroviral treatment of central nervous system HIV-1 infection: a review | Q34459372 | ||
| Saquinavir: a review of its use in boosted regimens for treating HIV infection | Q35147073 | ||
| Tight junction structure and ZO-1 content are identical in two strains of Madin-Darby canine kidney cells which differ in transepithelial resistance | Q36221153 | ||
| Sorting of sphingolipids in epithelial (Madin-Darby canine kidney) cells | Q36472379 | ||
| Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2). | Q39657896 | ||
| The effect of cell culture conditions on saquinavir transport through, and interactions with, MDCKII cells overexpressing hMDR1. | Q40632666 | ||
| Sulfate conjugating and transport functions of MDCK distal tubular cells | Q40664828 | ||
| Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs | Q40688656 | ||
| Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man. | Q40690604 | ||
| Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa? | Q40716273 | ||
| Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa? | Q40716277 | ||
| Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine | Q40753067 | ||
| Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and Multidrug resistance-associated protein 2 (MRP2/ABCC2) | Q40762600 | ||
| Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery | Q40923441 | ||
| Extracellular matrix protein-induced changes in human salivary epithelial cell organization and proliferation on a model biological substratum | Q40946578 | ||
| Transferrin receptor polarity and recycling accuracy in "tight" and "leaky" strains of Madin-Darby canine kidney cells | Q41513093 | ||
| HIV-protease inhibitors | Q41751665 | ||
| Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo models | Q42041789 | ||
| Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain | Q42059686 | ||
| Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. | Q44044782 | ||
| Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells | Q44087884 | ||
| Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A. | Q44285527 | ||
| Inhibition of Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake Is the Major Determinant in the Pharmacokinetic Interaction between Bosentan and Cyclosporin A in the Rat | Q44655928 | ||
| In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents | Q48497171 | ||
| Brain microvessel endothelial cells in tissue culture: a model for study of blood-brain barrier permeability | Q48729747 | ||
| Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors. | Q54059117 | ||
| Resistance to lipophilic cationic compounds in multidrug resistant leukemia cells. | Q54247932 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 377-389 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Drug Metabolism Reviews | Q5308857 |
| P1476 | title | Practical aspects of transporter model systems: a case study involving SQV. | |
| P478 | volume | 36 |
| Q37783447 | Impact of ATP-binding cassette transporters on human immunodeficiency virus therapy |
| Q45235236 | Pharmacokinetics and in vivo biodistribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine |
| Q44672643 | Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies |
Search more.